NDC 68025-084 – Relexxii

Methylphenidate Hydrochloride 72 mg/1 · Tablet, Extended Release · Oral

Human Prescription Drug DEA schedule CII

Product NDC68025-084

Product details

Brand name
Relexxii
Generic name
Methylphenidate hydrochloride
Labeler
Vertical Pharmaceuticals, LLC
Dosage form
Tablet, Extended Release
Route
Oral
Marketing category
NDA · NDA216117
Marketed since
June 23, 2022
Listing expires
December 31, 2026
Pharmacologic class
Central Nervous System Stimulant

Active ingredients

Uses, dosage, side effects and warnings for Relexxii →

Package NDC codes (1)

Package NDCDescriptionSince
68025-084-3030 TABLET, EXTENDED RELEASE in 1 BOTTLE (68025-084-30)Jun 23, 2022

Other Relexxii products